Treatment Evaluation of Melasma Patients in Dr. Hasan Sadikin General Hospital Bandung in period of 2013–2014
Abstract: Melasma is
hyperpigmentation of the skin especially located on face exposed to the
sunlight. This condition was characterized by brown to gray-brown macula with
irregular border. Difficulties in treatment of melasma arise from high tendency
for relapse, expensive cost, and high risk of side effects such as erythema,
sores, scales, and acne eruption. Study about evaluation of melasma therapy in
Dr. Hasan Sadikin General Hospital Bandung have not ever been done before.
Therefore, this study was conducted to evaluate therapy of melasma in the
Policlinic of Dermatology and Venereology, Dr. Hasan Sadikin General Hospital
Bandung.
Methods: This study was retrospectively descriptive. Data were obtained
from the new melasma patient medical records of Policlinic of Dermatology and
Venereology of Dr. Hasan Sadikin General Hospital Bandung in period of January
2013–2014. Sampling method used in this study was total sampling. Treatments of
melasma were evaluated by using Melasma Area Severity Index (MASI) score.
Collected data were processed and presented in frequency distribution and
percentage.
Results: The most used topical drugs were combination of hydroquinone and
tretinoin, and all of patients received sunblock. Most frequent time interval
was two weeks (30.8%). The most common side effect was erythema (10 out of 22).
Decreased MASI score was discovered in 48.1% and the most decreased category
was mild (14 out of 25).
Conclusions: The very common topical drugs used are hydroquinone and
tretinoin. The side effect of the treatment is Erythema. The decreased MASI
score is mild.
Keywords: Evaluation, melasma,
treatment
Author: Ayu Adzani Sabila,
Reti Hindritiani, Dimas Erlangga Luftimas
Journal Code: jpkedokterangg160294
